176 related articles for article (PubMed ID: 17174885)
21. Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure.
Goh KP; Lee HY; Lau DP; Supaat W; Chan YH; Koh AF
Int J Sport Nutr Exerc Metab; 2014 Feb; 24(1):2-13. PubMed ID: 23918588
[TBL] [Abstract][Full Text] [Related]
22. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1{alpha}.
Coste A; Louet JF; Lagouge M; Lerin C; Antal MC; Meziane H; Schoonjans K; Puigserver P; O'Malley BW; Auwerx J
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17187-92. PubMed ID: 18957541
[TBL] [Abstract][Full Text] [Related]
23. Endurance exercise increases the SIRT1 and peroxisome proliferator-activated receptor gamma coactivator-1alpha protein expressions in rat skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2008 Jul; 57(7):986-98. PubMed ID: 18555842
[TBL] [Abstract][Full Text] [Related]
24. In vino veritas? Pliny the Elder.
Fernandes CJ; Santucci Assunção M
Crit Care Med; 2012 Jun; 40(6):1991. PubMed ID: 22610219
[No Abstract] [Full Text] [Related]
25. Resveratrol is not a direct activator of SIRT1 enzyme activity.
Beher D; Wu J; Cumine S; Kim KW; Lu SC; Atangan L; Wang M
Chem Biol Drug Des; 2009 Dec; 74(6):619-24. PubMed ID: 19843076
[TBL] [Abstract][Full Text] [Related]
26. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.
Milne JC; Lambert PD; Schenk S; Carney DP; Smith JJ; Gagne DJ; Jin L; Boss O; Perni RB; Vu CB; Bemis JE; Xie R; Disch JS; Ng PY; Nunes JJ; Lynch AV; Yang H; Galonek H; Israelian K; Choy W; Iffland A; Lavu S; Medvedik O; Sinclair DA; Olefsky JM; Jirousek MR; Elliott PJ; Westphal CH
Nature; 2007 Nov; 450(7170):712-6. PubMed ID: 18046409
[TBL] [Abstract][Full Text] [Related]
27. Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1alpha in rats.
Lieber CS; Leo MA; Wang X; Decarli LM
Biochem Biophys Res Commun; 2008 May; 370(1):44-8. PubMed ID: 18342626
[TBL] [Abstract][Full Text] [Related]
28. Salutary effect of resveratrol on sepsis-induced myocardial depression.
Smeding L; Leong-Poi H; Hu P; Shan Y; Haitsma JJ; Horvath E; Furmli S; Masoom H; Kuiper JW; Slutsky AS; Parker TG; Plötz FB; dos Santos CC
Crit Care Med; 2012 Jun; 40(6):1896-907. PubMed ID: 22610192
[TBL] [Abstract][Full Text] [Related]
29. Life span extension by resveratrol, rapamycin, and metformin: The promise of dietary restriction mimetics for an healthy aging.
Mouchiroud L; Molin L; Dallière N; Solari F
Biofactors; 2010; 36(5):377-82. PubMed ID: 20848587
[TBL] [Abstract][Full Text] [Related]
30. Energy sensing factors PGC-1α and SIRT1 modulate PXR expression and function.
Buler M; Aatsinki SM; Skoumal R; Hakkola J
Biochem Pharmacol; 2011 Dec; 82(12):2008-15. PubMed ID: 21933665
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol improves health and survival of mice on a high-calorie diet.
Baur JA; Pearson KJ; Price NL; Jamieson HA; Lerin C; Kalra A; Prabhu VV; Allard JS; Lopez-Lluch G; Lewis K; Pistell PJ; Poosala S; Becker KG; Boss O; Gwinn D; Wang M; Ramaswamy S; Fishbein KW; Spencer RG; Lakatta EG; Le Couteur D; Shaw RJ; Navas P; Puigserver P; Ingram DK; de Cabo R; Sinclair DA
Nature; 2006 Nov; 444(7117):337-42. PubMed ID: 17086191
[TBL] [Abstract][Full Text] [Related]
32. Silencing metabolic disorders by novel SIRT1 activators.
Sakamoto K
Cell Metab; 2008 Jan; 7(1):3-4. PubMed ID: 18177718
[TBL] [Abstract][Full Text] [Related]
33. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress.
Kobayashi Y; Furukawa-Hibi Y; Chen C; Horio Y; Isobe K; Ikeda K; Motoyama N
Int J Mol Med; 2005 Aug; 16(2):237-43. PubMed ID: 16012755
[TBL] [Abstract][Full Text] [Related]
34. Sirtuins as regulators of metabolism and healthspan.
Houtkooper RH; Pirinen E; Auwerx J
Nat Rev Mol Cell Biol; 2012 Mar; 13(4):225-238. PubMed ID: 22395773
[TBL] [Abstract][Full Text] [Related]
35. NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response.
Liu TF; Vachharajani VT; Yoza BK; McCall CE
J Biol Chem; 2012 Jul; 287(31):25758-69. PubMed ID: 22700961
[TBL] [Abstract][Full Text] [Related]
36. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.
Fröjdö S; Durand C; Molin L; Carey AL; El-Osta A; Kingwell BA; Febbraio MA; Solari F; Vidal H; Pirola L
Mol Cell Endocrinol; 2011 Mar; 335(2):166-76. PubMed ID: 21241768
[TBL] [Abstract][Full Text] [Related]
37. Sirtuin activators: designing molecules to extend life span.
Camins A; Sureda FX; Junyent F; Verdaguer E; Folch J; Pelegri C; Vilaplana J; Beas-Zarate C; Pallàs M
Biochim Biophys Acta; 2010; 1799(10-12):740-9. PubMed ID: 20601277
[TBL] [Abstract][Full Text] [Related]
38. Seven sirtuins for seven deadly diseases of aging.
Morris BJ
Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
[TBL] [Abstract][Full Text] [Related]
39. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways.
Rodgers JT; Lerin C; Gerhart-Hines Z; Puigserver P
FEBS Lett; 2008 Jan; 582(1):46-53. PubMed ID: 18036349
[TBL] [Abstract][Full Text] [Related]
40. Protective role of SIRT1 in diabetic vascular dysfunction.
Orimo M; Minamino T; Miyauchi H; Tateno K; Okada S; Moriya J; Komuro I
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):889-94. PubMed ID: 19286634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
